Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP766882.RArolcoenji8Ruptx6QqdD6Df66Q2QW01P3ankQnS7RfI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP766882.RArolcoenji8Ruptx6QqdD6Df66Q2QW01P3ankQnS7RfI130_assertion type Assertion NP766882.RArolcoenji8Ruptx6QqdD6Df66Q2QW01P3ankQnS7RfI130_head.
- NP766882.RArolcoenji8Ruptx6QqdD6Df66Q2QW01P3ankQnS7RfI130_assertion description "[There was also a significant difference in the expression of IGLV3-21 between chronic lymphocytic leukemia and leukemic chronic lymphoproliferative disorders (29.4 vs 4.8%, P = 0.018).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP766882.RArolcoenji8Ruptx6QqdD6Df66Q2QW01P3ankQnS7RfI130_provenance.
- NP766882.RArolcoenji8Ruptx6QqdD6Df66Q2QW01P3ankQnS7RfI130_assertion evidence source_evidence_literature NP766882.RArolcoenji8Ruptx6QqdD6Df66Q2QW01P3ankQnS7RfI130_provenance.
- NP766882.RArolcoenji8Ruptx6QqdD6Df66Q2QW01P3ankQnS7RfI130_assertion SIO_000772 19220298 NP766882.RArolcoenji8Ruptx6QqdD6Df66Q2QW01P3ankQnS7RfI130_provenance.
- NP766882.RArolcoenji8Ruptx6QqdD6Df66Q2QW01P3ankQnS7RfI130_assertion wasDerivedFrom befree-20140225 NP766882.RArolcoenji8Ruptx6QqdD6Df66Q2QW01P3ankQnS7RfI130_provenance.
- NP766882.RArolcoenji8Ruptx6QqdD6Df66Q2QW01P3ankQnS7RfI130_assertion wasGeneratedBy ECO_0000203 NP766882.RArolcoenji8Ruptx6QqdD6Df66Q2QW01P3ankQnS7RfI130_provenance.